Molecular biology of fanconi anaemia - An old problem, a new insight

BioEssays

Volumn 24, Issue 5, 2002, Pages 439-448

  Ahmad, Shamim I ^a   Hanaoka, Fumio ^b   Kirk, Sandra H ^a  

^a NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; DNA BINDING PROTEIN; FANCC PROTEIN, HUMAN; FANCONI ANEMIA GROUP C PROTEIN; FANCONI ANEMIA PROTEIN; NUCLEAR PROTEIN; OXYGEN; PROTEIN;

APOPTOSIS; BIOLOGICAL MODEL; DNA DAMAGE; DNA REPAIR; FANCONI ANEMIA; GENETICS; HUMAN; METABOLISM; MUTATION; OXIDATIVE STRESS; PROTEIN BINDING; REVIEW;

APOPTOSIS; CELL CYCLE PROTEINS; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP C PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; HUMANS; MODELS, BIOLOGICAL; MUTATION; NUCLEAR PROTEINS; OXIDATIVE STRESS; OXYGEN; PROTEIN BINDING; PROTEINS;

EID: 0036013778     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.10082     Document Type: Review

References (90)

1. Bone marrow failure: Aplastic anemia and other primary bone marrow disorders
2. The molecular and cellular biology of Fanconi anemia
3. Loss of FanC function results in decreased hematopoietic stem cell repopulating ability
4. Evidence for at least eight Fanconi anemia genes
5. Complementation analysis in Fanconi anemia: Assignment of the reference FA-H patient to group A
6. Redox dependent toxicity of diepoxybutane and Mitomycin C in sea urchin embryogenesis
7. Fanconi anemia diagnosis and the diepoxybutane (DEB) test
8. Suppression of cytotoxic effect of mytomycin-C by superoxide dismutase in Fanconi's anemia and dyskeratosis congenita fibroblasts
9. Mitomycin C and diepoxybutane action mechanisms and FANCC protein functions: Further insight into the role for oxidative stress in Fanconi's anaemia phenotype
10. GSTT1-dependent induction of centromere negative and positive micronuclei by 1,2:3,4-diepoxybutane in cultured human lymphocytes
11. Mitomycin C-induced DNA damage in Fanconi anemia: Cross-linking or redox mediated effects?
12. Over-expression of thioredoxin in Fanconi anemia fibroblasts prevents the cytotoxic and DNA damaging effect of Mitomycin C and diepoxybutane
13. Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P-450 reductase
14. The FANCC protein interacts with GSTP1 to suppress apoptosis in a factor dependent hematopoietic cell line
15. Nuclear localization of the Fanconi anemia protein FANCC is required for functional activity
16. The role of oxygen metabolism for the pathological phenotype of Fanconi anemia
17. Mutagenic activity of ambient oxygen and mitomycin C in Fanconi anemia cells
18. Role of quinone mediated generation of hydroxyl radical in the induction of glutathione S-transferase gene expression
19. Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1
20. Hyper-sensitivity is a uniform and secondary defect in Fanconi anemia cells
21. Drug sensitivity spectra in Fanconi anemia lymphoblastoid cell lines of defined complementation group
22. Cytoskeleton alterations of erythrocytes from patients with Fanconi's anemia
23. Hydrogen peroxide: Effects on DNA, chromosome, cell cycle and apoptosis induction in Fanconi's anemia cell lines
24. Involvement of the Fanconi anemia protein FAC in repair process of oxidative DNA damage
25. Fanconi anemia cells have normal steady state levels and repair of oxidative DNA base modification sensitive to Fpg protein
26. Release of active oxygen radicals by leukocytes of Fanconi's anemia patients
27. 2-induced damage
28. Abnormal rearrangements associated V(D)J recombination in Fanconi anemia
29. Molecular spectra of HPRT deletion mutations in circulating T-lymphocytes in Fanconi anemia patients
30. Deficient DNA end joining activity in extracts from Fanconi anemia fibrobfasts
31. The fidelity of double strand breaks processing is impaired in complementation groups B and D of Fanconi anemia, a genetic instability syndrome
32. Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining
33. Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus
34. Expression cloning of a cDNA for the major Fanconi anemia gene, FAA
35. Positional cloning of the Fanconi anemia group A gene
36. The genomic organization of the Fanconi anemia group A (FAA) gene
37. High frequency of large intragenic deletions in the Fanconi anemia group A gene
38. Identification of Alu-mediated deletion in the Fanconi anemia gene FAA
39. Functional activity of the Fanconi anemia protein, FAA requires FAC binding and nuclear localization
40. Evidence for at least four Fanconi anemia genes including FACC on chromosome 9
41. Mutation analysis of the Fanconi anemia gene FACC
42. A common mutation in the FACC gene causes Fanconi anemia in Ashkenazi Jews
43. The IVS4 + 4A to T mutation of the Fanconi anemia gene FANNC is not associated with a severe phenotype in Japanese patients
44. Positional cloning of novel Fanconi anemia gene, FANCD2
45. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway
46. Repair of oxidized guanine in mammals: OGG1 genes
47. Isolation of cDNA representing the Fanconi Anemia complementation group E gene
48. The Fanconi anemia gene FANCF encodes a novel protein with homology to ROM
49. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG
50. The Fanconi anaemia group G gene FANCG is identical with XRCC9
51. Early parental diagnosis of Fanconi anemia in a twin pregnancy, using DNA analysis
52. Functional correction of Fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector
53. "Designer baby" cures sister
54. Carboxy terminal region of the Fanconi anemia protein, FANCG/ XRCC9, is required for functional activity
55. FANCA protein binds FANCG proteins in an intracellular complex
56. A novel genetic system to detect protein-protein interaction
57. Investigation of Fanconi anemia protein interactions by yeast two-hybrid analysis
58. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interacts in a functional nuclear complex
59. Direct interactions of the five known Fanconi anemia proteins suggest a common functional pathway
60. The Fanconi anemia pathway requires FAA Phosphorylation and FAA/ FAC nuclear accumulation
61. BASC, a super complex of BRCA1- associated proteins involved in the recognition and repair of aberrant DNA structures
62. Fanconi anemia and breast cancer: What's the connection?
63. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anemia
64. Human alpha spectrin II and the Fanconi anemia protein FANCA and FANCC interact to form a nuclear complex
65. Fanconi anemia, complementation group A, cells are defective in ability to produce incisions at sites of psoralen interstrand cross-links
66. Human alpha spectrin II and the FANCA, and FANCG proteins bind to DNA containing psoralen interstrand cross-links
67. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF
68. In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions
69. Plzf regulates limb and axial skeletal patterning
70. Expression of the Fanconi anemia group A gene (FANCA) during mouse embryogenesis
71. The effect of the Fanconi anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation
72. Arrest of S-phase progression is impaired in Fanconi anemia cells
73. Effects of oxidants and antioxidants on chromosomal breakage in Fanconi anemia lymphocytes
74. Fanconi anemia mutation causes cellular susceptibility to ambient oxygen
75. Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage and cell cycle-regulated manner
76. Inactivation of Fanconi anemia group C gene augments interferon-γ-induced apoptosis responses in heamatopoletic cell
77. Abnormal lymphokine production; a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha
78. Fanconi anemia protein, FANCG, is a phosphoprotein and is upregulated with FANCA after TNF-alpha treatment
79. The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors
80. The role of STATs in transcriptional control and their impact on cellular function
81. Functional correction of FA-C cells with FANCC expresses the expression of interferon gamma-inducible genes
82. Overexpression of the Fanconi anemia group C gene (FAC) protects hematopoietic progenitors from death induced by Fas-mediated apoptosis
83. Interferon-gamma-induced apoptotic responses of Fanconi anemia group C hematopoietic progenitor cells involve caspase 8-dependent activation of caspase 3 family member
84. Mice with a targeted disruption of the Fanconi anemia homolog Fanca
85. Localization of the Fanconi anemia complementation group A gene to chromosome 16q24.3
86. Characterization of the exon structure of the Fanconi anemia group C gene by vectorette PCR
87. Localization of the Fanconi anemia complementation group D gene to a 200-kb region on chromosome 3p25.3
88. The Fanconi anemia group E gene, FANCE, maps to chromosome 6P
89. Localization of Fanconi anemia gene to chromosome 9p